Diligence memo · auto-generated · as of July 2, 2026
Cytosorbents Corp
Cytosorbents Corp looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Cytosorbents Corp operates in Other Health Care, based in MONMOUTH JUNCTION.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cytosorbents Corp has raised $1.8M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.1M on 2013-06-21.
Most recent recorded round closed around 2013-09-30.
Valuation (modeled)modeled
Provath models Cytosorbents Corp at approximately $18M (range $630K–$145M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.43× the median modeled value of Seed Other Health Care companies in 2013–2015 (251 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 3 months.
Last raise 12.8 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 45% of Other Health Care peers (5377 compared).
Modeled value ranks above 46% of those peers.
Closest niche peers: RightCare Solutions, Inc., Vios Medical, Inc., HealthEdge Investors DD Holdings, LLC, Center at Northridge, LLC, Fresenius Medical Care NKDHC, LLC.
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.